Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC Therapy for POF
NCT02372474Phase 2Completed
- Sponsor
- Al-Azhar University
- Start
- Mar 2012
- Primary completion
- Dec 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in primary ovarian insufficiency (POI), sponsored by Al-Azhar University. Started Mar 2012; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02372474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372474.